Statement of theBoard of Directors and Executive Management

 

Today the Board of Directors and Executive Management have discussed and approved
the Annual Report of Zealand Pharma A/S for the financial year 1 January – 31
December 2013.
 
The Annual Report has been prepared in accordance with International Financial Reporting
Standards as adopted by the EU and Danish disclosure requirements for listed companies.
 
In our opinion the financial statements give a true and fair view of the Company’s financial
position as of 31 December 2013 and of the results of the Company’s operations and
cash flows for the financial year 1 January – 31 December 2013.
 
In our opinion the management’s review includes a fair review about the development of the Company’s operations and economical conditions, the results for the year and the Company’s financial position as well as a review of the more significant risks and uncertainty the Company faces, in accordance with the Danish disclosure requirements for listed companies.
 
We recommend that the Annual Report be approved at the annual general meeting.
 
Glostrup, 20 March 2014